Combination Antithrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease

NCT04142125 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Stroke
Intracranial Atherosclerotic Disease

Interventions

DRUG: Rivaroxaban 2.5 Mg Oral Tablet bid
DRUG: Acetylsalicyclic acid 81 mg tablet qd

Sponsor

Population Health Research Institute